- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech Undervalued based on future growth
South Korean Pharmaceuticals & Biotech Undervalued based on future growth
Results
3
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
3 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
A000640 | ₩105,900.00 | -6.4% | 4.9% | ₩662.0b | ₩150,000.00 | PE12x | E40.8% | 1.8% | ||
A001060 | ₩23,150.00 | -1.7% | -34.9% | ₩578.6b | ₩41,500.00 | PE8.2x | E14.6% | 1.7% | ||
A003220 | ₩13,990.00 | 0.4% | -10.7% | ₩299.9b | ₩20,500.00 | PE18.7x | E45.6% | 2.1% |
Page 1 of 1